P R E S E N TAT I O N S


T E C H N O L O G I C A L S T R AT E G I E S :
THE LAST LINE OF DEFENSE

A N T H O N Y J . D E S T E FA N O , P H . D .
S R . V I C E P R E S I D E N T,
COMPENDIAL SCIENCE
U N I T E D S TAT E S P H A R M AC O P E I A
SEPTEMBER 28, 2012
N AT I O N A L P R E S S C L U B
WWW.SAFEMEDICINES.ORG
Technological Strategies: The Last
        Line of Defense

        Anthony J. DeStefano, Ph.D.
  Sr. Vice President, Compendial Science
        United States Pharmacopeia
A Global Problem Requiring Global Solutions


   About 80% of all API made outside the US
   Similar trends in Drug Product manufacturing
   Detection of counterfeit or substandard products
    often impossible to detect visually – need a
    technical solution
   Solutions need to be standardized to facilitate rapid
    global transfer and adoption
   What are the roles of industry, government and the
    pharmacopeia?
    – How can we work synergistically and avoid duplication of
      effort?
                                                                 3
Industry – Counterfeit vs. Substandard

   Industry needs the most sophisticated and specialized
    technology
   Manufacturers must deal with
    – Sub-standard materials
    – Reverse-engineered nearly identical copies
   The latter require specialized tools
    – Specialized microscopy to assess if the die used in the tablet
      manufacture was one used by the company
    – Examination of impurity profiles of API and excipients to correlate with
      known sources of materials
   The former are also difficult – can’t be everywhere – how
    do you find the material and stop its manufacture?

                                                                           4
Governments - Standardization


   Can help drive standardization
    – Unified track and trace in the US
    – Reach out globally to standardize
   Need to target a solution that really addresses the
    issue
    – Is tracking at the lot level sufficient or a burden that still leaves a
      gap?
    – Is tracking at the unit level feasible in a short time frame?
   Need to develop a compelling global case that the
    gain is worth the pain


                                                                         5
Governments – Broad Reach


   How does one find counterfeits?
   Tools good enough to rapidly say “hold to assess
    authenticity”
   Sufficient people/equipment to check materials
    entering the country
    – Very small percentage checked now
    – Can’t stop the problem if we can’t detect it
   Technology needs to be standardized, portable,
    inexpensive and readily available


                                                       6
Examples of Tools Available

   Track and trace technology (e.g., bar code readers)
   Infrared spectroscopy (mid and near IR)
   Portable NMR
   Portable GC-MS
   Portable x-ray diffraction
   Microscopes
   HPLC and other traditional testing equipment



                                                      7
The Need for Standardization

   Identification/verification tools are critical
   Only as good as the standards against which the
    material is tested
   What does good look like, and how do you know?
   What is a “close enough” match with the database?
   How do you minimize false positives (manufacturer
    risks) and false negatives (consumer risks)?
   Answers require standardization and industry,
    governments and perhaps standard-setting bodies
    working together
                                                      8
Spectral Libraries – The Need for Standardization

   Spectral libraries (fingerprints against which the
    material in question is matched) are no better than
    the materials and methodology with which they are
    constructed
   Materials and products vary
    – Lot-to-lot differences (impurities, variations in formulation,
      uniformity of manufacture)
    – Regional differences (formulations for US, Africa,…)
    – Changes during the shelf life of a product
   Methodology varies
    – Sampling strategies
    – Protocols for obtaining spectra
    – Different manufacturers of the same technology – platform and
      data analysis differences                                  9
A Role for the Pharmacopeia?

   USP currently has access to nearly 3000 drug
    substance and drug product reference materials
   USP has a global presence, is used in over 140
    countries and has worked with many government
    across the globe
   As an independent third party, USP can provide
    confidentiality and global reach
   Combined with industry and government efforts, may
    be able to increase the “sets of eyes” out looking for
    counterfeits
   May be able to provide some of the standardization
    needed to make the current tools more effective
                                                       10
USING ADVANCED TECHNOLOGIES TO STOP COUNTERFEITERS


                                    Handheld Raman




                   Portable GC-MS
                                                       Portable NMR




Handheld XRF




 GS1 Handheld
 Barcode Scanner



                                    Portable NIR-MSP              Handheld NIR
12
USP Spectral Library Development Process


                    Materials        Method                          Data
 Instrument                                           Data
                   Acquisition,   Development
Acquisition &                      (Attributes,
                                                   Acquisition &   Analysis &
                    Storage &
  Validation        Retention     DoE, Analyzer)    Validation     Validation




                USP Quality Assurance SEAL (CoA & SOP)



            Global Public
                                  Education            Technical
             Awareness
                                   Training             Services
            & Promotion
NASA USING SPECTRAL LIBRARY TO DETECT MINERAL
COMPOSITION ON MARS




                                                14
Summary

   Counterfeiters are many and sophisticated so the people
    and equipment trying to stop them need to be as well
   Standardization is critical to speed and accuracy
    – Minimize false positives or false negatives
   Coordination of efforts is critical
    – Avoid duplication of effort
    – Avoid missed opportunities to apply technology
    – Avoid gaps in technology and optimize coverage
   Technological strategies, in all their manifestations, are
    critical to success
   The public expects us to succeed - we need to provide
    them with the protection they expect and deserve
                                                                 15
Technological Strategies: The Last Line of Defense by Anthony DeStefano, United States Pharmacopeia

More Related Content

PPTX
Dr. Marvin Shepherd: Grey Market Vendor Activities and Drug Shortages in Texa...
PPTX
Panel 1: Patient Safety Moderated by Scott Williams
PPTX
PSM Interchange 2014 Panel 2: Linda Marks, Criminal Prosecutions: Patient Safety
PPT
Beyond Avastin: The ongoing dangers of counterfeit drugs to American patients
PPTX
Dr. Timothy Mackey: Clear and Present Danger: Availability of Dangerous, Unap...
PPTX
Luncheon Speaker: Bejon Misra, Partnership for Safe Medicines India
PDF
Be aware, take action: fight counterfeits, keep patients safer
PPTX
Welcome remarks - Scott LaGanga Executive Director
Dr. Marvin Shepherd: Grey Market Vendor Activities and Drug Shortages in Texa...
Panel 1: Patient Safety Moderated by Scott Williams
PSM Interchange 2014 Panel 2: Linda Marks, Criminal Prosecutions: Patient Safety
Beyond Avastin: The ongoing dangers of counterfeit drugs to American patients
Dr. Timothy Mackey: Clear and Present Danger: Availability of Dangerous, Unap...
Luncheon Speaker: Bejon Misra, Partnership for Safe Medicines India
Be aware, take action: fight counterfeits, keep patients safer
Welcome remarks - Scott LaGanga Executive Director

Viewers also liked (17)

PPTX
Supply Chain Integrity: The Patient Care Interface by David Chen, The Society...
PPTX
"Counterfeit Medicines: Threat to Public Health and Safety," Congressional Br...
PPTX
PSM Interchange 2014 Panel 3: Daniel Burke: The Impacts of Fake Online Pharma...
PPTX
PSM Interchange 2014: Scott LaGanga, Welcome to the 2014 Interchange
PPTX
PSM Interchange 2014: Madame Lihong Gu, Partnership for Safe Medicines, China
PPTX
Panel 4 - Linda Marks Senior Counsel: Overview of New Developments in Interna...
PPTX
PSM Interchange 2014: Tim Mackey, After Avastin: What Have We Learned, What C...
PPTX
PSM Interchange 2014 Panel 1: Tom Kubic, Global Trends Situation Report 2013
PPTX
PSM Interchange 2014 Panel 3: Todd Brown: Non-FDA Approved Foreign Drugs Are ...
PPTX
The UK (MHRA) approach to combating Falsified Medicines by Gerald Heddell, MHRA
PPTX
Panel 2 Moderated by Dr. Bryan Liang Overview of Fake Online Pharmacy Issues
PPTX
Americans patients exposed to counterfeit and black market medication
PPTX
Counterfeit Drug Infographics for Interchange 2013
PPTX
PSM Interchange 2014 Panel 3: Kenneth 'Mac' McCall
PPT
Counterfeit drugs 101 for Healthcare Providers
PPTX
PSM Interchange 2014: Marv Shepherd, United State Pharmacopeia Good Distribut...
PDF
"Protecting Patients from Counterfeit Medicines," Congressional Briefing, Mar...
Supply Chain Integrity: The Patient Care Interface by David Chen, The Society...
"Counterfeit Medicines: Threat to Public Health and Safety," Congressional Br...
PSM Interchange 2014 Panel 3: Daniel Burke: The Impacts of Fake Online Pharma...
PSM Interchange 2014: Scott LaGanga, Welcome to the 2014 Interchange
PSM Interchange 2014: Madame Lihong Gu, Partnership for Safe Medicines, China
Panel 4 - Linda Marks Senior Counsel: Overview of New Developments in Interna...
PSM Interchange 2014: Tim Mackey, After Avastin: What Have We Learned, What C...
PSM Interchange 2014 Panel 1: Tom Kubic, Global Trends Situation Report 2013
PSM Interchange 2014 Panel 3: Todd Brown: Non-FDA Approved Foreign Drugs Are ...
The UK (MHRA) approach to combating Falsified Medicines by Gerald Heddell, MHRA
Panel 2 Moderated by Dr. Bryan Liang Overview of Fake Online Pharmacy Issues
Americans patients exposed to counterfeit and black market medication
Counterfeit Drug Infographics for Interchange 2013
PSM Interchange 2014 Panel 3: Kenneth 'Mac' McCall
Counterfeit drugs 101 for Healthcare Providers
PSM Interchange 2014: Marv Shepherd, United State Pharmacopeia Good Distribut...
"Protecting Patients from Counterfeit Medicines," Congressional Briefing, Mar...
Ad

Similar to Technological Strategies: The Last Line of Defense by Anthony DeStefano, United States Pharmacopeia (20)

PDF
CBI Anti-Counterfeiting Presentation
PDF
Overview of anti counterfeiting technologies and Opportunities for India
PDF
PMPS Anti-Counterfeiting Article EDXRD
PPT
Supply Chain Safety
PPTX
Anti counterfeit packaging
PDF
Counterfeit prevention & detection strategies, how to do it, when to do it.
PPT
Anti Counterfeiting - Playing Roulette Or Chess?
PDF
20231019to20_OIP-2023_SFriedrichs.pdf
PDF
Emerging Trends & Developments, Common Inspection Deficiencies and Other Conc...
PDF
The Holography Times, March 2012, Volume 6, Issue no 17
PDF
ASPA & IPAMA Workshop on Integration of Authentication Solutions at PRINTPACK...
PPT
The european product safety system and the supply chain
PDF
Best_Practices_for_Authentication_Track_Trace_in_Pharmaceutical_Products_Pack...
PDF
Security, Economics, Technology and the Sustainability Paradox
PDF
Applying some simple system design concepts to aid better planning: SIPOC, Sy...
PDF
Regulatory intelligence
PPT
Products Liability & the Middle Market
PDF
Quality Assurance Tools in Nanomaterials in Food and Consumer Products_2015
PDF
2016 10-27 cdx webinar with vde
PDF
Avoiding Counterfeit Risk: How to mitigate part and supplier risk
 
CBI Anti-Counterfeiting Presentation
Overview of anti counterfeiting technologies and Opportunities for India
PMPS Anti-Counterfeiting Article EDXRD
Supply Chain Safety
Anti counterfeit packaging
Counterfeit prevention & detection strategies, how to do it, when to do it.
Anti Counterfeiting - Playing Roulette Or Chess?
20231019to20_OIP-2023_SFriedrichs.pdf
Emerging Trends & Developments, Common Inspection Deficiencies and Other Conc...
The Holography Times, March 2012, Volume 6, Issue no 17
ASPA & IPAMA Workshop on Integration of Authentication Solutions at PRINTPACK...
The european product safety system and the supply chain
Best_Practices_for_Authentication_Track_Trace_in_Pharmaceutical_Products_Pack...
Security, Economics, Technology and the Sustainability Paradox
Applying some simple system design concepts to aid better planning: SIPOC, Sy...
Regulatory intelligence
Products Liability & the Middle Market
Quality Assurance Tools in Nanomaterials in Food and Consumer Products_2015
2016 10-27 cdx webinar with vde
Avoiding Counterfeit Risk: How to mitigate part and supplier risk
 
Ad

More from The Partnership For Safe Medicines (12)

PDF
Family advocate webinar 2/2/2022
PDF
Crime and Policy III: Partnership for Safe Medicines overview for 2021
PDF
The Partnership for Safe Medicines Congressional Briefing, September 24, 2019
PDF
Cartels and Counterfeits: International Organized Crime And Counterfeit Drugs
PDF
“Can You Safely Implement Canadian Importation?
PDF
"Problems with importing medicine from Canada" - webinar slides
PDF
NeedyMeds May 2017 webinar
PPTX
Counterfeit Drugs in America: 2017 Overview
PPTX
Drug importation: Maine's Experience with Unreliable Foreign 'Pharmacies,' 20...
PPTX
"The Insidious Path of Counterfeit Cancer Drugs from Turkey to Toledo: How d...
PPTX
PSM Interchange 2014 Panel 3, Libby Baney, The Impact of Fake Online Pharmac...
Family advocate webinar 2/2/2022
Crime and Policy III: Partnership for Safe Medicines overview for 2021
The Partnership for Safe Medicines Congressional Briefing, September 24, 2019
Cartels and Counterfeits: International Organized Crime And Counterfeit Drugs
“Can You Safely Implement Canadian Importation?
"Problems with importing medicine from Canada" - webinar slides
NeedyMeds May 2017 webinar
Counterfeit Drugs in America: 2017 Overview
Drug importation: Maine's Experience with Unreliable Foreign 'Pharmacies,' 20...
"The Insidious Path of Counterfeit Cancer Drugs from Turkey to Toledo: How d...
PSM Interchange 2014 Panel 3, Libby Baney, The Impact of Fake Online Pharmac...

Recently uploaded (20)

PDF
giants, standing on the shoulders of - by Daniel Stenberg
PDF
Transform-Your-Supply-Chain-with-AI-Driven-Quality-Engineering.pdf
PDF
Transform-Quality-Engineering-with-AI-A-60-Day-Blueprint-for-Digital-Success.pdf
PDF
NewMind AI Weekly Chronicles – August ’25 Week IV
PDF
Decision Optimization - From Theory to Practice
PDF
ment.tech-Siri Delay Opens AI Startup Opportunity in 2025.pdf
PDF
Examining Bias in AI Generated News Content.pdf
PDF
Altius execution marketplace concept.pdf
PDF
Ensemble model-based arrhythmia classification with local interpretable model...
PDF
The-2025-Engineering-Revolution-AI-Quality-and-DevOps-Convergence.pdf
PDF
EIS-Webinar-Regulated-Industries-2025-08.pdf
PDF
Planning-an-Audit-A-How-To-Guide-Checklist-WP.pdf
PPTX
Internet of Everything -Basic concepts details
PDF
Transform-Your-Streaming-Platform-with-AI-Driven-Quality-Engineering.pdf
PDF
Auditboard EB SOX Playbook 2023 edition.
PDF
Lung cancer patients survival prediction using outlier detection and optimize...
PDF
AI.gov: A Trojan Horse in the Age of Artificial Intelligence
PDF
Human Computer Interaction Miterm Lesson
PDF
A symptom-driven medical diagnosis support model based on machine learning te...
PDF
IT-ITes Industry bjjbnkmkhkhknbmhkhmjhjkhj
giants, standing on the shoulders of - by Daniel Stenberg
Transform-Your-Supply-Chain-with-AI-Driven-Quality-Engineering.pdf
Transform-Quality-Engineering-with-AI-A-60-Day-Blueprint-for-Digital-Success.pdf
NewMind AI Weekly Chronicles – August ’25 Week IV
Decision Optimization - From Theory to Practice
ment.tech-Siri Delay Opens AI Startup Opportunity in 2025.pdf
Examining Bias in AI Generated News Content.pdf
Altius execution marketplace concept.pdf
Ensemble model-based arrhythmia classification with local interpretable model...
The-2025-Engineering-Revolution-AI-Quality-and-DevOps-Convergence.pdf
EIS-Webinar-Regulated-Industries-2025-08.pdf
Planning-an-Audit-A-How-To-Guide-Checklist-WP.pdf
Internet of Everything -Basic concepts details
Transform-Your-Streaming-Platform-with-AI-Driven-Quality-Engineering.pdf
Auditboard EB SOX Playbook 2023 edition.
Lung cancer patients survival prediction using outlier detection and optimize...
AI.gov: A Trojan Horse in the Age of Artificial Intelligence
Human Computer Interaction Miterm Lesson
A symptom-driven medical diagnosis support model based on machine learning te...
IT-ITes Industry bjjbnkmkhkhknbmhkhmjhjkhj

Technological Strategies: The Last Line of Defense by Anthony DeStefano, United States Pharmacopeia

  • 1. P R E S E N TAT I O N S T E C H N O L O G I C A L S T R AT E G I E S : THE LAST LINE OF DEFENSE A N T H O N Y J . D E S T E FA N O , P H . D . S R . V I C E P R E S I D E N T, COMPENDIAL SCIENCE U N I T E D S TAT E S P H A R M AC O P E I A SEPTEMBER 28, 2012 N AT I O N A L P R E S S C L U B WWW.SAFEMEDICINES.ORG
  • 2. Technological Strategies: The Last Line of Defense Anthony J. DeStefano, Ph.D. Sr. Vice President, Compendial Science United States Pharmacopeia
  • 3. A Global Problem Requiring Global Solutions  About 80% of all API made outside the US  Similar trends in Drug Product manufacturing  Detection of counterfeit or substandard products often impossible to detect visually – need a technical solution  Solutions need to be standardized to facilitate rapid global transfer and adoption  What are the roles of industry, government and the pharmacopeia? – How can we work synergistically and avoid duplication of effort? 3
  • 4. Industry – Counterfeit vs. Substandard  Industry needs the most sophisticated and specialized technology  Manufacturers must deal with – Sub-standard materials – Reverse-engineered nearly identical copies  The latter require specialized tools – Specialized microscopy to assess if the die used in the tablet manufacture was one used by the company – Examination of impurity profiles of API and excipients to correlate with known sources of materials  The former are also difficult – can’t be everywhere – how do you find the material and stop its manufacture? 4
  • 5. Governments - Standardization  Can help drive standardization – Unified track and trace in the US – Reach out globally to standardize  Need to target a solution that really addresses the issue – Is tracking at the lot level sufficient or a burden that still leaves a gap? – Is tracking at the unit level feasible in a short time frame?  Need to develop a compelling global case that the gain is worth the pain 5
  • 6. Governments – Broad Reach  How does one find counterfeits?  Tools good enough to rapidly say “hold to assess authenticity”  Sufficient people/equipment to check materials entering the country – Very small percentage checked now – Can’t stop the problem if we can’t detect it  Technology needs to be standardized, portable, inexpensive and readily available 6
  • 7. Examples of Tools Available  Track and trace technology (e.g., bar code readers)  Infrared spectroscopy (mid and near IR)  Portable NMR  Portable GC-MS  Portable x-ray diffraction  Microscopes  HPLC and other traditional testing equipment 7
  • 8. The Need for Standardization  Identification/verification tools are critical  Only as good as the standards against which the material is tested  What does good look like, and how do you know?  What is a “close enough” match with the database?  How do you minimize false positives (manufacturer risks) and false negatives (consumer risks)?  Answers require standardization and industry, governments and perhaps standard-setting bodies working together 8
  • 9. Spectral Libraries – The Need for Standardization  Spectral libraries (fingerprints against which the material in question is matched) are no better than the materials and methodology with which they are constructed  Materials and products vary – Lot-to-lot differences (impurities, variations in formulation, uniformity of manufacture) – Regional differences (formulations for US, Africa,…) – Changes during the shelf life of a product  Methodology varies – Sampling strategies – Protocols for obtaining spectra – Different manufacturers of the same technology – platform and data analysis differences 9
  • 10. A Role for the Pharmacopeia?  USP currently has access to nearly 3000 drug substance and drug product reference materials  USP has a global presence, is used in over 140 countries and has worked with many government across the globe  As an independent third party, USP can provide confidentiality and global reach  Combined with industry and government efforts, may be able to increase the “sets of eyes” out looking for counterfeits  May be able to provide some of the standardization needed to make the current tools more effective 10
  • 11. USING ADVANCED TECHNOLOGIES TO STOP COUNTERFEITERS Handheld Raman Portable GC-MS Portable NMR Handheld XRF GS1 Handheld Barcode Scanner Portable NIR-MSP Handheld NIR
  • 12. 12
  • 13. USP Spectral Library Development Process Materials Method Data Instrument Data Acquisition, Development Acquisition & (Attributes, Acquisition & Analysis & Storage & Validation Retention DoE, Analyzer) Validation Validation USP Quality Assurance SEAL (CoA & SOP) Global Public Education Technical Awareness Training Services & Promotion
  • 14. NASA USING SPECTRAL LIBRARY TO DETECT MINERAL COMPOSITION ON MARS 14
  • 15. Summary  Counterfeiters are many and sophisticated so the people and equipment trying to stop them need to be as well  Standardization is critical to speed and accuracy – Minimize false positives or false negatives  Coordination of efforts is critical – Avoid duplication of effort – Avoid missed opportunities to apply technology – Avoid gaps in technology and optimize coverage  Technological strategies, in all their manifestations, are critical to success  The public expects us to succeed - we need to provide them with the protection they expect and deserve 15

Editor's Notes

  • #15: Looking at rocks and soils from a distance, ChemCam on Mars Rover will fire a laser and analyze the elemental composition of vaporized materials from areas smaller than 1 millimeter on the surface of Martian rocks and soils. An on-board spectrograph, with a spectral library, will provide unprecedented detail about minerals and microstructures in rocks by measuring the composition of the resulting plasma -- an extremely hot gas made of free-floating ions and electrons.From 23 feet (7 meters) away, ChemCam will be able to: Rapidly identify the kind of rock being studied (for example, whether it is volcanic or sedimentary); Determine the composition of soils and pebbles; Measure the abundance of all chemical elements, including trace elements and those that might be hazardous to humans; Recognize ice and minerals with water molecules in their crystal structures; Measure the depth and composition of weathering rinds on rocks; and, Provide visual assistance during drilling of rock cores.The rover can send spectral information directly to Earth, it can also uplink information to other spacecraft orbiting Mars.